VCEL Form 144: Insider Plans to Sell 10,000 Shares ($357.7K)
Form 144 filing for Vericel Corporation (VCEL) shows a planned sale of 10,000 common shares held by the reporting person through Fidelity Brokerage Services.
Rhea-AI Filing Summary
Form 144 filing for Vericel Corporation (VCEL) shows a planned sale of 10,000 common shares held by the reporting person through Fidelity Brokerage Services. The filing lists an approximate aggregate market value of $357,700 for the shares to be sold and indicates the shares represent part of an option granted on 02/11/2020 and acquired on 09/02/2025, with cash payment at exercise. The issuer's total shares outstanding are shown as 50,460,205, so the proposed block is a small fraction of the company. The filing also discloses a prior sale of 10,000 common shares by the same person on 06/02/2025 for $400,924. The notice affirms the signer does not possess undisclosed material adverse information.
Positive
- Clear compliance disclosure under Rule 144 with broker, quantity, and market value specified
- Exercise details provided: option granted 02/11/2020 and acquired/exercised 09/02/2025 with cash payment
- Prior sale disclosed for transparency: 10,000 shares sold 06/02/2025 for $400,924
Negative
- None.
Insights
TL;DR: Routine insider notice of intended sale; size is immaterial relative to outstanding shares and follows a recent sale.
The Form 144 documents an intended sale of 10,000 common shares via a broker with an aggregate market value of $357,700. Given the issuer's stated 50.46 million shares outstanding, the planned sale represents roughly 0.02% of outstanding shares, which is immaterial from a market-capitalization perspective. The filing also records a prior sale of 10,000 shares on 06/02/2025 for $400,924, confirming recent liquidity activity by the same individual. This filing meets disclosure requirements under Rule 144 and provides transparency but does not, by itself, indicate a material change to the company's capital structure or operations.
TL;DR: Properly executed insider disclosure; affirms compliance with Rule 144 and includes representation about material nonpublic information.
The notice includes required seller and broker details, the acquisition method (option granted 02/11/2020, exercised 09/02/2025), and the signature attestation regarding material adverse information. It also lists prior sales within three months, satisfying aggregation and reporting rules. From a governance perspective, the filing documents procedural compliance and transparency by the reporting person, without revealing any new governance actions or changes in management holdings beyond the disclosed sales.
FAQ
What does Vericel Corporation's (VCEL) Form 144 report?
When were the securities acquired and how were they obtained?
What attestation does the filer make in the Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.